Irland - Englisch - HPRA (Health Products Regulatory Authority)

lexon pharmaceuticals (ireland) limited - trazodone hydrochloride - oral solution - 50/5 milligram(s)/millilitre - other antidepressants; trazodone

Irland - Englisch - HPRA (Health Products Regulatory Authority)

kinedexe uk limited - trazodone hydrochloride - oral solution - 50/5 mg/ml - other antidepressants - other antidepressants - relief of symptoms in all types of depression including depression accompanied by anxiety. symptoms of depression likely to respond in the first week of treatment include depressed mood, insomnia, anxiety, somatic symptoms and hypochondriasis.

Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

zentiva pharma uk ltd - trazodone hydrochloride - oral solution - 10mg/1ml

Malta - Englisch - Medicines Authority

syri pharma limited floor 0 1 wml, 1 windmill lane dublin 2, d02 f206, ireland - trazodone hydrochloride - oral solution - trazodone hydrochloride 50 mg/5ml - psychoanaleptics

Irland - Englisch - HPRA (Health Products Regulatory Authority)

nrim limited - trazodone hydrochloride - oral solution - 50/5 mg/ml

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

dispensing solutions, inc. - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride 50 mg - trazodone hydrochloride tablets usp are indicated for the treatment of depression. the efficacy of trazodone hydrochloride tablets usp has been demonstrated in both inpatient and outpatient settings and for depressed patients with and without prominent anxiety. the depressive illness of patients studied corresponds to the major depressive episode criteria of the american psychiatric association’s diagnostic and statistical manual, lll.a major depressive episode implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least four of the following eight symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigability, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and suicidal ideation or attempts. trazodone hydrochloride tablets are contraindicated in

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

dispensing solutions, inc. - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride 50 mg - trazodone hydrochloride tablets usp are indicated for the treatment of depression. the efficacy of trazodone hydrochloride tablets usp has been demonstrated in both inpatient and outpatient settings and for depressed patients with and without prominent anxiety. the depressive illness of patients studied corresponds to the major depressive episode criteria of the american psychiatric association’s diagnostic and statistical manual, lll.a major depressive episode implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least four of the following eight symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigability, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and suicidal ideation or attempts. trazodone hydrochloride tablets are contraindicated in

Irland - Englisch - HPRA (Health Products Regulatory Authority)

key pharmaceuticals ltd - trazodone hydrochloride - oral solution - 50/5 milligram(s)/millilitre - other antidepressants; trazodone

Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

zentiva pharma uk ltd - trazodone hydrochloride - oral solution - 20mg/1ml

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (mdd) in adults. trazodone hydrochloride tablets are contraindicated in: - patients taking, or within 14 days of stopping, monoamine oxidase inhibitors (maois), including maois such as linezolid or intravenous methylene blue, because of an increased risk of serotonin syndrome [see warnings and precautions (5.2), drug interactions (7.1)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antidepressants during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for antidepressants at 1-844-405- 6185 or visiting online at https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/antidepressants/ risk summary published prospective cohort studies, case series, and case reports over several decades with trazodone use in pregnant women have not identified any drug-associated